Factor X Deficiency
|
0.800 |
Biomarker
|
disease |
CTD_human |
|
|
|
Factor X Deficiency
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Factor X Deficiency
|
0.800 |
Biomarker
|
disease |
BEFREE |
Immunological assay of factor X (radioimmunoassay) showed 0.47 microgram/ml in the second case and 0.15 microgram/ml in the third case, from which our cases were considered to be classical factor X deficiency.
|
7233424 |
1981 |
Factor X Deficiency
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
The most common group of factor X deficiency was associated with abnormal activation of factor X by all three pathways.
|
3970856 |
1985 |
Factor X Deficiency
|
0.800 |
Biomarker
|
disease |
CLINGEN |
The molecular basis of blood coagulation.
|
3286010 |
1988 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Enzymatic amplification technique was used to isolate all eight exons and sequences around the splice junctions, putative promoter, and polyadenylation sites of human factor X DNA from a patient with factor X deficiency.
|
2790181 |
1989 |
Factor X Deficiency
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Enzymatic amplification technique was used to isolate all eight exons and sequences around the splice junctions, putative promoter, and polyadenylation sites of human factor X DNA from a patient with factor X deficiency.
|
2790181 |
1989 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Enzymatic amplification technique was used to isolate all eight exons and sequences around the splice junctions, putative promoter, and polyadenylation sites of human factor X DNA from a patient with factor X deficiency.
|
2790181 |
1989 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
"Molecular defect (Gla+14----Lys) and its functional consequences in a hereditary factor X deficiency (factor X ""Vorarlberg"")."
|
1973167 |
1990 |
Factor X Deficiency
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343.
|
1985698 |
1991 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343.
|
1985698 |
1991 |
Factor X Deficiency
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion.
|
1939653 |
1991 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glu102Lys) in the second EGF-like domain.
|
7669671 |
1995 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Factor XKetchikan: a variant molecule in which Gly replaces a Gla residue at position 14 in the light chain.
|
7860069 |
1995 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Functional consequences of the Ser334-->Pro mutation in a human factor X variant (factor XMarseille).
|
8529633 |
1995 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Factor X Stockton: a mild bleeding diathesis associated with an active site mutation in factor X.
|
8845463 |
1996 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Factor XSt. Louis II. Identification of a glycine substitution at residue 7 and characterization of the recombinant protein.
|
8910490 |
1996 |
Factor X Deficiency
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Inherited factor X deficiency: molecular genetics and pathophysiology.
|
9198147 |
1997 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Factor X Nagoya 1 and Nagoya 2: a CRM- factor X deficiency and a dysfunctional CRM+ factor X deficiency characterized by substitution of Arg306 by Cys and of Gly366 by Ser, respectively.
|
9531027 |
1998 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
A family with hereditary factor X deficiency with a point mutation Gla32 to Gln in the Gla domain (factor X Tokyo).
|
10468877 |
1999 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
The impact of Glu102Lys on the factor X function in a patient with a doubly homozygous factor X deficiency (Gla14Lys and Glu102Lys).
|
10739379 |
2000 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
The factor X (F10) genes of 14 unrelated individuals with factor X deficiency (12 familial and two sporadic cases) were sequenced yielding a total of 13 novel mutations.
|
10746568 |
2000 |
Factor X Deficiency
|
0.800 |
Biomarker
|
disease |
CLINGEN |
The factor X (F10) genes of 14 unrelated individuals with factor X deficiency (12 familial and two sporadic cases) were sequenced yielding a total of 13 novel mutations.
|
10746568 |
2000 |
Factor X Deficiency
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice.
|
10739370 |
2000 |
Factor X Deficiency
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The factor X (F10) genes of 14 unrelated individuals with factor X deficiency (12 familial and two sporadic cases) were sequenced yielding a total of 13 novel mutations.
|
10746568 |
2000 |